# A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder

> **NCT02234011** · PHASE2 · TERMINATED · sponsor: **Mclean Hospital** · enrollment: 1 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02234011
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Terminated due to difficulty in recruiting participants.
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02234011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02234011, "A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02234011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*